Compare RNA & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | RYN |
|---|---|---|
| Founded | 2012 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.3B |
| IPO Year | 2020 | N/A |
| Metric | RNA | RYN |
|---|---|---|
| Price | $71.76 | $21.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 4 |
| Target Price | ★ $69.26 | $27.25 |
| AVG Volume (30 Days) | ★ 2.9M | 1.3M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 13.44% |
| EPS Growth | N/A | ★ 373.89 |
| EPS | N/A | ★ 5.07 |
| Revenue | $20,868,000.00 | ★ $1,293,371,000.00 |
| Revenue This Year | $64.11 | N/A |
| Revenue Next Year | $37.25 | N/A |
| P/E Ratio | ★ N/A | $8.42 |
| Revenue Growth | ★ 106.27 | 60.70 |
| 52 Week Low | $21.51 | $21.06 |
| 52 Week High | $71.79 | $32.07 |
| Indicator | RNA | RYN |
|---|---|---|
| Relative Strength Index (RSI) | 77.56 | 40.44 |
| Support Level | $71.42 | $21.19 |
| Resistance Level | $71.76 | $22.29 |
| Average True Range (ATR) | 0.41 | 0.44 |
| MACD | -0.73 | 0.09 |
| Stochastic Oscillator | 88.32 | 39.84 |
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.